Neurocrine Biosciences | NBIX - Employees Total Number

Stock Price
127.68
Daily Change
-2.51 -1.93%
Monthly
-2.63%
Yearly
19.63%
Q2 Forecast
124.95

Neurocrine Biosciences reported 1.8K in Employees for its fiscal year ending in December of 2024.





Employees Change Date
AbbVie 55K 5K Dec/2024
Acadia Pharmaceuticals 653 56 Dec/2024
Agios Pharmaceuticals 486 103 Dec/2024
ALKERMES 1.8K 300 Dec/2024
Alnylam Pharmaceuticals 2.23K 130 Dec/2024
Amgen 28K 1.3K Dec/2024
Biogen 7.6K 35 Dec/2024
BioMarin Pharmaceutical 3.04K 361 Dec/2024
Cytokinetics 498 75 Dec/2024
Enanta Pharmaceuticals 145 15 Sep/2023
Exelixis 1.15K 163 Dec/2025
Gilead Sciences 17.6K 400 Dec/2024
Halozyme Therapeutics 350 23 Dec/2024
Incyte 2.62K 93 Dec/2024
Ionis Pharmaceuticals 1.07K 142 Dec/2024
Nektar Therapeutics 137 79 Dec/2023
Neurocrine Biosciences 1.8K 400 Dec/2024
Pfizer 81K 7K Dec/2024
Prothena 163 10 Dec/2024
Regeneron Pharmaceuticals 13.45K 1.6K Dec/2023
Repligen 1.78K 5 Dec/2024
Rigel Pharmaceuticals 147 8 Dec/2023
Sarepta Therapeutics 1.37K 58 Dec/2024
Ultragenyx Pharmaceutical 1.29K 18 Dec/2024
Vertex Pharmaceuticals 6.1K 700 Dec/2024
Xoma 13 1 Dec/2023